ImmunoPrecise Antibodies Ltd.

TSXV:IPA Voorraadrapport

Marktkapitalisatie: CA$162.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

ImmunoPrecise Antibodies Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Jennifer Bath

Algemeen directeur

CA$1.9m

Totale compensatie

Percentage CEO-salaris34.9%
Dienstverband CEO4.8yrs
Eigendom CEO0.4%
Management gemiddelde ambtstermijn1.3yrs
Gemiddelde ambtstermijn bestuur4.5yrs

Recente managementupdates

Recent updates

We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Oct 20
We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Dec 23
Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Nov 25
Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Analyse CEO-vergoeding

Hoe is Jennifer Bath's beloning veranderd ten opzichte van ImmunoPrecise Antibodies's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$8m

Jul 31 2019n/an/a

-CA$9m

Apr 30 2019CA$1mCA$505k

-CA$8m

Jan 31 2019n/an/a

-CA$6m

Oct 31 2018n/an/a

-CA$6m

Jul 31 2018n/an/a

-CA$5m

Apr 30 2018CA$65kCA$65k

-CA$5m

Compensatie versus markt: Jennifer's total compensation ($USD1.39M) is above average for companies of similar size in the Canadian market ($USD178.89K).

Compensatie versus inkomsten: Jennifer's compensation has been consistent with company performance over the past year.

CEO

Jennifer Bath

4.8yrs

Tenure

CA$1,856,482

Compensatie

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Jennifer Bath
CEO, President & Non-Independent Director4.8yrsCA$1.86m0.44%
CA$ 707.3k
Brad McConn
Chief Financial Officerless than a yearCA$432.71k0.032%
CA$ 52.0k
Ilse Roodink
Chief Scientific Officer1.3yrsCA$514.16k0.013%
CA$ 21.7k
David Orton
Chief Operating Officer5.7yrsgeen gegevensgeen gegevens
Carla Dahl
Vice President of Marketing1.3yrsgeen gegevens0.040%
CA$ 65.0k
Barry Duplantis
Vice President of Client Relationsno datageen gegevens0.0048%
CA$ 7.8k

1.3yrs

Gemiddelde duur

Ervaren management: IPA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Jennifer Bath
CEO, President & Non-Independent Director4.5yrsCA$1.86m0.44%
CA$ 707.3k
James Kuo
Independent Chairman of the Board5.9yrsCA$130.84k0.10%
CA$ 162.5k
Gregory Smith
Independent Director6.2yrsCA$95.66k0.17%
CA$ 282.7k
Guy Champagne
Member of Advisory Board4.3yrsCA$55.00kgeen gegevens
Robert Burke
Independent Director4.9yrsCA$87.99k0.12%
CA$ 201.5k
Dion Neame
Member of Strategic Advisory Board1.5yrsgeen gegevensgeen gegevens
Anna Pettersson
Independent Directorless than a yearCA$75.55kgeen gegevens

4.5yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: IPA's board of directors are considered experienced (4.5 years average tenure).